Electronics
Samsung to invest $356bn over five years in strategic sectors
South Korean conglomerate targets long-term growth in chips, biopharmaceuticals
Biotechnology
Biotechnology
American VC firm Arch launches $3bn biomedical fund with eye on Japan
Fund looks to help develop startups short on capital, co-founder says
COVID vaccines
Japan pharma cranks up output of COVID vaccine materials
Global supplies shortage and dependence on West spell urgency, opportunity
Biotechnology
Hong Kong biotech startup Medera bets on 'heart in a jar'
Company aims to cut drug development time and costs by replacing animal testing
Biotechnology
Asian sugar king Mitr Phol to start bioplastics production
Thai group partners with Marubeni to build new pillar for growth
Finance
Singapore's DBS logs record profit despite online banking stumble
Southeast Asia's largest lender deals with regulator's wrath over service outage
Business Spotlight
Brains on a chip: Why startups are combining cells and silicon
Australia's Cortical Labs is working on 'holy grail' of AI: general intelligence
Startups
Japan's unicorns gain foothold from AI to materials: Nikkei survey
Startups see strong growth but still lag behind overseas peers
Interview
Temasek pauses China tech investments amid Beijing crackdown
Singapore state investor wants regulatory clarity as Didi, others face scrutiny
Biotechnology
U.S. biotech unicorn eyes bigger China presence from Singapore
10x Genomics opens Asia headquarters in city-state, supporting COVID-19 research
Agriculture
Philippines stirs controversy with genetically modified rice
Critics take aim at nutrient-enriched Golden Rice, but government says it is safe
China tech
'Huawei of genomics' plots global expansion on COVID windfall
Threat of US sanctions clouds outlook for China's BGI
Biotechnology
South Korea's SD Biosensor leaps in Seoul trading debut
Company's COVID test kit success attracts investors amid hot local IPO market
COVID vaccines
Moderna's COVID-19 vaccine shows promise against Delta variant
Study indicates only modest decrease in response compared to original strain
Caixin
Chinese mRNA vaccine developer raises a record $200m
Fresh funds to finance clinical trials and production of vaccine candidate
Agriculture
China learns to stop worrying and embrace GMO crops
State issues permits to grow genetically modified corn to ensure food security
COVID vaccines
Moderna boosting COVID-19 vaccine capacity
Company targets up to 3bn shots in 2022, doubling its previous forecast
Markets
Hong Kong stock index plans 100 members to meet China growth
Hang Seng Index overhaul to boost tech weighting and reduce financials
Arts
BOOKS: New book chronicles four-decade fight against Alzheimer's
Japan's Susumu Shimoyama brings scientific development of latest drug to life
Startups
US and Chinese startup investments swell amid pandemic
Money flows into health care and digital transformation-related sectors
